St. Clair Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.11M Buy
14,219
+1,000
+8% +$80.7K 0.29% 45
2026
Q1
$1.15M Sell
13,219
-1,443
-10% -$138K 0.3% 46
2025
Q4
$1.41M Buy
14,662
+3,500
+31% +$340K 0.36% 39
2025
Q3
$1.06M Hold
11,162
0.28% 45
2025
Q2
$973K Hold
11,162
0.25% 46
2025
Q1
$1M Hold
11,162
0.28% 44
2024
Q4
$892K Hold
11,162
0.26% 48
2024
Q3
$1M Hold
11,162
0.29% 47
2024
Q2
$879K Sell
11,162
-1,173
-10% -$96.2K 0.28% 46
2024
Q1
$1.07M Hold
12,335
0.35% 43
2023
Q4
$1.02M Hold
12,335
0.35% 44
2023
Q3
$967K Hold
12,335
0.38% 38
2023
Q2
$1.09M Hold
12,335
0.42% 37
2023
Q1
$994K Buy
12,335
+9,446
+327% +$770K 0.43% 37
2022
Q4
$225K Buy
+2,889
New +$234K 0.14% 58

Other funds holding MDT

St. Clair Advisors's MDT Position: Q2 2026 in Review

St. Clair Advisors increased its Medtronic (MDT) stake by 7.6% in Q2 2026, buying an estimated $80.7K and bringing the position to 14,219 shares worth $1.11M. The position accounts for 0.29% of the portfolio, ranked #45.

St. Clair Advisors first reported a position in MDT in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.41M in Q4 2025. 535 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • St. Clair Advisors held 14,219 shares of Medtronic worth $1.11M as of Q2 2026.
  • St. Clair Advisors bought 1,000 Medtronic shares in Q2 2026, an estimated $80.7K.
  • Medtronic made up 0.29% of St. Clair Advisors's portfolio in Q2 2026, its #45 holding.
  • St. Clair Advisors first reported a position in Medtronic in Q4 2022 and has held it in 15 quarters since.
  • St. Clair Advisors's Medtronic position peaked at $1.41M in Q4 2025.
  • 535 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on St. Clair Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.